LifeSci Acquisition in a definitive proxy filing set a Dec. 22 meeting for shareholders to vote on the SPAC’s proposed merger with Vincera Pharma. The combined company is expected to have approximately $60 million in cash at closing if shareholders approve the deal. LifeSCi said as of Dec. 3 there was approximately $65.7 million held in trust. Read more.
Related Posts
IronNet in Talks to Merge With Gabelli’s LGL Systems
LGL is said to be discussing raising new equity to support a transaction that’s set to value the combined entity at about $1.2 billion.
Playboy & Mountain Crest Complete Merger
Announced four months ago, the deal is valued at about $381 million.
Phoenix Acquisition Limited Files for $40M IPO
The new SPAC intends to focus on operating businesses in the TMT industry in Asia or North America.
M3-Brigade Acquisition III Files for $400M IPO
The new SPAC will focus on businesses or companies with an enterpirse value of at least $1 billion, are based in North America, and which have been impacted positively or negatively by the COVID-19 pandemic or businesses in the renewable energy sector.